Evidence map›Paper›PMID 20929224›Full record

ArticleJournal of the American Chemical Society2010

Allylic C-H acetoxylation with a 4,5-diazafluorenone-ligated palladium catalyst: a ligand-based strategy to achieve aerobic catalytic turnover.

Alison N Campbell, Paul B White, Ilia A Guzei, Shannon S Stahl

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Review
  2. C(spJournal of the American Chemical Society · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Late-Stage Diversification: A Motivating Force in Organic Synthesis.Journal of the American Chemical Society · 2021
    Article
  14. Article
  15. Can Donor Ligands Make Pd(OAc)Journal of the American Chemical Society · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alison N CampbellDepartment of Chemistry, University of Wisconsin-Madison, 1101 University Avenue, Madison, Wisconsin 53706, United States.
Paul B White
Ilia A Guzei
Shannon S Stahl

Funding

Palladium-Catalyzed Oxidative Amination of AlkenesR01GM067173 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI STAHL, SHANNON S · 2003 to 2015
$3.6M
New Mechanisms for Alkene Functionalization Using Redox Active LigandsF32GM087890 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI CAMPBELL, ALISON NICOLE · 2009 to 2010
$86k
NIGMS NIH HHS F32 GM087890NIGMS NIH HHS F32-GM087890NIGMS NIH HHS R01 GM067173NIGMS NIH HHS R01-GM67163
6 · The paper itself

Abstract

Pd-catalyzed C-H oxidation reactions often require the use of oxidants other than O(2). Here we demonstrate a ligand-based strategy to replace benzoquinone with O(2) as the stoichiometric oxidant in Pd-catalyzed allylic C-H acetoxylation. Use of 4,5-diazafluorenone (1) as an ancillary ligand for Pd(OAc)(2) enables terminal alkenes to be converted to linear allylic acetoxylation products in good yields and selectivity under 1 atm O(2). Mechanistic studies have revealed that 1 facilitates C-O reductive elimination from a π-allyl-Pd(II) intermediate, thereby eliminating the requirement for benzoquinone in this key catalytic step.

Indexed as

AerobiosisCarbonCatalysisFluorenesHydrogenLigandsOxygenPalladium4,5-diazafluorenoneCarbonFluorenesHydrogenLigandsOxygenPalladium

Identifiers

PMID20929224
PMCPMC2971663

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.